EZH2与α-SMA在风湿性心脏瓣膜病合并心房颤动患者心肌组织中的表达变化研究

doi:10.12092/j.issn.1009-2501.2019.12.009

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (12): 1371-1375.doi: 10.12092/j.issn.1009-2501.2019.12.009

EZH2与α-SMA在风湿性心脏瓣膜病合并心房颤动患者心肌组织中的表达变化研究

徐盛松，陶辉，石开虎，丁季飞

安徽医科大学第二附属医院心胸外科，安徽医科大学心血管病研究中心，合肥 230601，安徽

收稿日期:2019-01-17 修回日期:2019-05-24 出版日期:2019-12-26 发布日期:2020-01-07
通讯作者: 石开虎，男，博士后，博士生导师，研究方向：房颤与心肌纤维化。 E-mail：shikaihu@gmail.com
作者简介:徐盛松，男，硕士研究生，副主任医师，研究方向：房颤心肌重构。 E-mail：2384258388@qq.com
基金资助:
国家自然科学基金项目(81570295)；安徽省自然科学基金项目(1808085MH231)

Expression and clinical significance of EZH2 and α-SMA in myocardium of patients with rheumatic heart disease with atrial fibrillation

XU Shengsong, TAO Hui, SHI Kaihu, DING Jifei

Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Anhui Medical University , Cardiovascular Disease Research Center of Anhui Medical University, Hefei 230601, Anhui, China

Received:2019-01-17 Revised:2019-05-24 Online:2019-12-26 Published:2020-01-07

摘要/Abstract

摘要：

目的:探讨风湿性心脏瓣膜病合并心房颤动(AF)患者心肌组织中组蛋白-赖氨酸N-甲基转移酶EZH2与α-平滑肌肌动蛋白（α-SMA）的表达变化研究。方法:将20例风湿性心脏瓣膜病接受瓣膜置换手术患者，于体外循环前切取的右心耳组织作为研究对象，分为两组：AF组(n=10)和窦性心律(SR)组(n=10)，分别应用Masson染色观察心肌组织中胶原沉积情况，应用免疫组化、qRT-PCR、Western blot法检测心肌组织中EZH2与α-SMA表达变化。结果:Masson染色提示AF组与SR组相比，AF组中胶原沉积明显增多，胶原容积分数增加(P<0.05)；免疫组化检测显示AF组与SR组相比，AF组EZH2与α-SMA蛋白表达增加(P<0.05)。同时，Western blot检测显示AF组与SR组相比，AF组EZH2与α-SMA蛋白表达增加(P<0.05)。qRT-PCR显示AF组与SR组相比，AF组EZH2与α-SMA mRNA表达增加(P<0.05)。结论:EZH2与α-SMA在房颤组织中高表达，提示EZH2与α-SMA可能促进风湿性心脏瓣膜病合并心房颤动发生发展。

关键词: 风湿性心脏病, 心房颤动, 组蛋白-赖氨酸N-甲基转移酶EZH2, α-SMA

Abstract:

AIM: To investigate the expression correlation between histone-lysine N-methyltransferase EZH2 and α-SMA in the patients with rheumatic heart disease and atrial fibrillation (AF). METHODS: Tissues of auricula dextra were removed from 20 patients with rheumatic heart disease undergoing cardiac surgery for correction to valvular defect. According to the definition of AF, 20 patients were divided into group of AF group and of sinus rhythm (SR) group (n=10). The collagen deposition in myocardial tissue was detected by Masson's trichrome stain. The expression of EZH2 and α-SMA were detected by immunohistochemistry, qRT-PCR and Western blot. RESULTS:Masson staining results revealed that the collagen deposition and the comparisons of CVF were significantly increased in the AF heart tissue compared with the SR control(P<0.05). Immunohistochemistry indicated that comparing with the SR group; the expressions of EZH2 and α-SMA protein were significantly increased in AF group (P<0.05). Western blot indicated that compared with the SR group, the expressions of EZH2 and α-SMA protein were significantly increased in AF group(P<0.05). Moreover, qRT-PCR found that compared with the SR group, the expressions of EZH2 and α-SMA mRNA were significantly increased in AF group(P<0.05). CONCLUSION: High expressions of EZH2 and α-SMA indicate EZH2 and α-SMA can regulate the development of AF.

Key words: rheumatic heart disease, atrial fibrillation, histone-lysine-N-methyltransferase EZH2, &alpha, smooth muscle actin

中图分类号:

R541.3

徐盛松，陶辉，石开虎，丁季飞. EZH2与α-SMA在风湿性心脏瓣膜病合并心房颤动患者心肌组织中的表达变化研究[J]. 中国临床药理学与治疗学, 2019, 24(12): 1371-1375.

XU Shengsong, TAO Hui, SHI Kaihu, DING Jifei. Expression and clinical significance of EZH2 and α-SMA in myocardium of patients with rheumatic heart disease with atrial fibrillation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1371-1375.

参考文献

［1］Giannopoulos G, Vrachatis D, Kossyvakis C, et al. Effect of postablation statin treatment on arrhythmia recurrence in patients with paroxysmal atrial fibrillation［J］. J Cardiovasc Pharmacol, 2018, 72(6):285-290.
［2］Mei B, Liu H, Yang S, et al. Long non-coding RNA expression profile in permanent atrial fibrillation patients with rheumatic heart disease［J］. Eur Rev Med Pharmacol Sci, 2018,22(20):6940-6947.
［3］Tao H, Shi KH, Yang JJ, et al. Epigenetic mechanisms in atrial fibrillation: New insights and future directions［J］. Trends Cardiovasc Med, 2016, 26(4):306-318.
［4］Zhao K, He J, Wang YF, et al. EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression［J］. Gene, 2018 , 686:118-124.
［5］Wetterslev M,Haase N,Hassager C, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review［J］ .Intensive Care Med, 2019, undefined: undefined.
［6］Gullón A, Sánchez Fuentes D, López-de-Sá E, et al. Use of oral anticoagulants in complex clinical situations with atrial fibrillation［J］. Med Clin (Barc), 2018,150 Suppl 1:8-24.
［7］Zhang X, Li H, Kou W, et al. Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left atrial remodelling［J］ .Arch Med Sci, 2019, 15(3): 632-640.
［8］Nortamo S, Ukkola O, Kiviniemi A, et al. Impaired cardiac autonomic regulation and long-term risk of atrial fibrillation in patients with coronary artery disease［J］. Heart Rhythm, 2018,15(3):334-340.
［9］Zhang D, Hu X, Henning RH, et al. Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation［J］. Cardiovasc Res, 2016, 109(4):519-526.
［10］Zhou Y, Lv X, Qu H, et al. Differential expression of circular RNAs in hepatic tissue in a model of liver fibrosis and functional analysis of their target genes［J］.Hepatol Res, 2019, 49(3): 324-334.
［11］Jalan-Sakrikar N, De Assuncao TM, Shi G, et al. Proteasomal degradation of enhancer of zeste homologue 2 in cholangiocytes promotes biliary fibrosis［J］. Hepatology, 2019.
［12］Tsou PS, Campbell P, Amin MA, et al. Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma［J］. Proc Natl Acad Sci U S A, 2019, 116(9): 3695-3702.
［13］Grindheim JM, Nicetto D, Donahue G, et al. Polycomb repressive complex 2 proteins EZH1 and EZH2 regulate timing of postnatal hepatocyte maturation and fibrosis by repressing genes with euchromatic promoters in mice［J］ .Gastroenterology, 2019, 156(6): 1834-1848.
［14］Zhou X, Xiong C, Tolbert E, et al. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis［J］. FASEB J, 2018, fj201800237R.
［15］Holm Nielsen S,Willumsen N, Leeming DJ, et al. Serological assessment of activated fibroblasts by alpha-smooth muscle actin (α-SMA): A noninvasive biomarker of activated fibroblasts in lung disorders［J］.Transl Oncol, 2019, 12(2): 368-374.
［16］Yang Y,Chen XX,Li WX, et al. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis［J］.J Cell Mol Med, 2017, 21(10): 2317-2328.

[1]	韩超，杨柳，张秋玲，潘竞锵，徐俊. 黄芩苷对哮喘大鼠气道重塑作用的实验研究[J]. 中国临床药理学与治疗学, 2017, 22(7): 749-754.
[2]	王世奇，胡烨文，陈晓敏，王健，叶红华 . 不同强度华法林在冠状动脉粥样硬化性心脏病并发心房颤动患者中的效果对比[J]. 中国临床药理学与治疗学, 2017, 22(12): 1410-1414.
[3]	伍继初, 罗参香, 欧阳泽伟. 胺碘酮及氯沙坦对慢性房颤射频消融术后心房结构及房颤复发的影响[J]. 中国临床药理学与治疗学, 2015, 20(3): 318-322.
[4]	张涛, 郭成贤, 温纯洁, 周宏灏. ACE基因I/D多态性与风湿性心脏病的相关性研究[J]. 中国临床药理学与治疗学, 2013, 18(5): 550-554.
[5]	张涛, 温纯洁, 沈冬亚, 周宏灏. 风湿性心脏病易感基因多态性研究进展[J]. 中国临床药理学与治疗学, 2013, 18(10): 1186-1191.
[6]	汤依群, 孙书娟, 尹月淼, 汪旻晖, 黄潞, 单娇娇. 阵发性房颤诱发大鼠心房肌电重构特征研究[J]. 中国临床药理学与治疗学, 2011, 16(11): 1205-1209.
[7]	胡立群, 章琦, 陈莉, 许凤娟, 汤洁. 伊布利特转复老年心房颤动的临床研究[J]. 中国临床药理学与治疗学, 2009, 14(12): 1419-1422.
[8]	吴家斌, 许春萱, 张建成, 陈林, 林立芳, 胡锡衷. 心房颤动患者氯电流相关通道CIC-3 基因表达的研究[J]. 中国临床药理学与治疗学, 2005, 10(6): 651-654.
[9]	何胜虎, 徐遐华, 刘晓东, 陈述, 孙磊, 张薏. 胺碘酮与心律平对阵发性心房颤动疗效的比较[J]. 中国临床药理学与治疗学, 2003, 8(3): 292-294.

EZH2与α-SMA在风湿性心脏瓣膜病合并心房颤动患者心肌组织中的表达变化研究

Expression and clinical significance of EZH2 and α-SMA in myocardium of patients with rheumatic heart disease with atrial fibrillation

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 9

编辑推荐

Metrics

本文评价